Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Security

Skinvisible, Inc. Common Stock · SKVI

SKVIOTCCommon stockHistorical · closed Jan 4, 2019CIK 1085277Updated Nov 17, 2026

Company: SKINVISIBLE, INC. →

Name history
SKINVISIBLE INC · through Aug 14, 2019
Current security for this SEC filerSKVI · OTC

SKVI price & chart

Provider market data
Historical security

This listing closed Jan 4, 2019. Live provider charts are shown only for current listings.

Current security: SKVI

About the company

Inc. Skinvisible Pharmaceuticals, a wholly-owned subsidiary of Skinvisible, Inc., is a pioneering research and development company specializing in licensing proprietary topical and transdermal formulations utilizing its patented polymer skin delivery system; Invisicare. This innovative technology provides life-cycle management and distinctive enhancements for both topical and transdermal delivery products. Invisicare formulated as a lotion or cream, effectively adheres active ingredients to the skin facilitating a controlled release of the active to and/or through the skin and into the blood stream over time. Skinvisible has recently developed formulations for the potential treatment of obesity, along with over forty dermatology related conditions including rare skin disorders. For further details, please visit www.skinvisible.com.

8-K · 2025-01-23 · 0001663577-25-000033

Company description from the cited filing.

In the news

No coverage from other publishers is available.

Recent filings

  1. 10-Q filing

    10-Q · 2026-11-16 · 0001663577-26-000345

  2. 10-Q filing

    10-Q · 2026-08-13 · 0001663577-26-000248

  3. 10-Q filing

    10-Q · 2026-05-13 · 0001663577-26-000141

  4. 10-K filing

    10-K · 2026-03-31 · 0001663577-26-000087

  5. 10-Q filing

    10-Q · 2025-11-13 · 0001663577-25-000309

Show 5 more recent filings
  1. 10-Q filing

    10-Q · 2025-08-13 · 0001663577-25-000261

  2. 10-Q filing

    10-Q · 2025-05-14 · 0001663577-25-000136

  3. 10-K filing

    10-K · 2025-04-14 · 0001663577-25-000110

  4. NT 10-K filing

    NT 10-K · 2025-03-31 · 0001663577-25-000088

  5. Regulation FD Disclosure

    Items 7.01, 9.01

    8-K · 2025-01-23 · 0001663577-25-000033

Financials

FY 2025 · USD
Net income-1,064,034USD · FY 2025
Source

10-K · 2026-03-31 · 0001663577-26-000087

2025-01-01 to 2025-12-31

Cash— · FY 2025
Operating income-496,315USD · FY 2025
Source

10-K · 2026-03-31 · 0001663577-26-000087

2025-01-01 to 2025-12-31

Diluted EPS— · FY 2025

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemQ3 2025Q3 2024Q2 2026Q2 2025Q2 2024Q1 2026Q1 2025Q1 2024FY 2025FY 2024FY 2023FY 2022
ASSETS
AssetsUSD133,623
Source

10-Q · 2025-11-13 · 0001663577-25-000309

As of 2025-09-30

148,643
Source

10-Q · 2024-11-19 · 0001663577-24-000294

As of 2024-09-30

123,334
Source

10-Q · 2026-08-13 · 0001663577-26-000248

As of 2026-06-30

143,375
Source

10-Q · 2025-08-13 · 0001663577-25-000261

As of 2025-06-30

163,058
Source

10-Q · 2024-08-15 · 0001663577-24-000234

As of 2024-06-30

119,419
Source

10-Q · 2026-05-13 · 0001663577-26-000141

As of 2026-03-31

149,554
Source

10-Q · 2025-05-14 · 0001663577-25-000136

As of 2025-03-31

153,403
Source

10-Q · 2024-05-15 · 0001663577-24-000137

As of 2024-03-31

127,567
Source

10-K · 2026-03-31 · 0001663577-26-000087

As of 2025-12-31

158,217
Source

10-K · 2025-04-14 · 0001663577-25-000110

As of 2024-12-31

162,869
Source

10-K · 2024-04-16 · 0001663577-24-000119

As of 2023-12-31

246,793
Source

10-K · 2023-03-30 · 0001663577-23-000137

As of 2022-12-31

Current assets:
Accounts Receivable, after Allowance for Credit Loss, CurrentUSD5,000
Source

10-Q · 2025-11-13 · 0001663577-25-000309

As of 2025-09-30

1,000
Source

10-Q · 2024-11-19 · 0001663577-24-000294

As of 2024-09-30

5,000
Source

10-Q · 2026-08-13 · 0001663577-26-000248

As of 2026-06-30

5,000
Source

10-Q · 2025-08-13 · 0001663577-25-000261

As of 2025-06-30

5,000
Source

10-Q · 2024-08-15 · 0001663577-24-000234

As of 2024-06-30

5,000
Source

10-Q · 2026-05-13 · 0001663577-26-000141

As of 2026-03-31

470
Source

10-Q · 2025-05-14 · 0001663577-25-000136

As of 2025-03-31

—5,000
Source

10-K · 2026-03-31 · 0001663577-26-000087

As of 2025-12-31

5,000
Source

10-K · 2025-04-14 · 0001663577-25-000110

As of 2024-12-31

5,000
Source

10-K · 2024-04-16 · 0001663577-24-000119

As of 2023-12-31

—
Assets, CurrentUSD28,469
Source

10-Q · 2025-11-13 · 0001663577-25-000309

As of 2025-09-30

27,404
Source

10-Q · 2024-11-19 · 0001663577-24-000294

As of 2024-09-30

33,301
Source

10-Q · 2026-08-13 · 0001663577-26-000248

As of 2026-06-30

33,102
Source

10-Q · 2025-08-13 · 0001663577-25-000261

As of 2025-06-30

35,882
Source

10-Q · 2024-08-15 · 0001663577-24-000234

As of 2024-06-30

24,390
Source

10-Q · 2026-05-13 · 0001663577-26-000141

As of 2026-03-31

38,305
Source

10-Q · 2025-05-14 · 0001663577-25-000136

As of 2025-03-31

30,689
Source

10-Q · 2024-05-15 · 0001663577-24-000137

As of 2024-03-31

27,531
Source

10-K · 2026-03-31 · 0001663577-26-000087

As of 2025-12-31

42,028
Source

10-K · 2025-04-14 · 0001663577-25-000110

As of 2024-12-31

35,460
Source

10-K · 2024-04-16 · 0001663577-24-000119

As of 2023-12-31

109,946
Source

10-K · 2023-03-30 · 0001663577-23-000137

As of 2022-12-31

Prepaid Expense and Other Assets, CurrentUSD5,232
Source

10-Q · 2025-11-13 · 0001663577-25-000309

As of 2025-09-30

4,200
Source

10-Q · 2024-11-19 · 0001663577-24-000294

As of 2024-09-30

6,750
Source

10-Q · 2026-08-13 · 0001663577-26-000248

As of 2026-06-30

10,390
Source

10-Q · 2025-08-13 · 0001663577-25-000261

As of 2025-06-30

6,300
Source

10-Q · 2024-08-15 · 0001663577-24-000234

As of 2024-06-30

—6,847
Source

10-Q · 2025-05-14 · 0001663577-25-000136

As of 2025-03-31

—2,319
Source

10-K · 2026-03-31 · 0001663577-26-000087

As of 2025-12-31

9,100
Source

10-K · 2025-04-14 · 0001663577-25-000110

As of 2024-12-31

7,980
Source

10-K · 2024-04-16 · 0001663577-24-000119

As of 2023-12-31

9,495
Source

10-K · 2023-03-30 · 0001663577-23-000137

As of 2022-12-31

LIABILITIES AND EQUITY
LiabilitiesUSD10,138,047
Source

10-Q · 2025-11-13 · 0001663577-25-000309

As of 2025-09-30

10,016,111
Source

10-Q · 2024-11-19 · 0001663577-24-000294

As of 2024-09-30

10,908,832
Source

10-Q · 2026-08-13 · 0001663577-26-000248

As of 2026-06-30

9,897,554
Source

10-Q · 2025-08-13 · 0001663577-25-000261

As of 2025-06-30

9,744,922
Source

10-Q · 2024-08-15 · 0001663577-24-000234

As of 2024-06-30

10,649,384
Source

10-Q · 2026-05-13 · 0001663577-26-000141

As of 2026-03-31

9,629,306
Source

10-Q · 2025-05-14 · 0001663577-25-000136

As of 2025-03-31

9,466,818
Source

10-Q · 2024-05-15 · 0001663577-24-000137

As of 2024-03-31

10,390,348
Source

10-K · 2026-03-31 · 0001663577-26-000087

As of 2025-12-31

9,404,164
Source

10-K · 2025-04-14 · 0001663577-25-000110

As of 2024-12-31

9,185,912
Source

10-K · 2024-04-16 · 0001663577-24-000119

As of 2023-12-31

6,887,396
Source

10-K · 2023-03-30 · 0001663577-23-000137

As of 2022-12-31

Stockholders’ equity:
Common Stock, Value, IssuedUSD5,404
Source

10-Q · 2025-11-13 · 0001663577-25-000309

As of 2025-09-30

4,890
Source

10-Q · 2024-11-19 · 0001663577-24-000294

As of 2024-09-30

5,404
Source

10-Q · 2026-08-13 · 0001663577-26-000248

As of 2026-06-30

5,404
Source

10-Q · 2025-08-13 · 0001663577-25-000261

As of 2025-06-30

4,890
Source

10-Q · 2024-08-15 · 0001663577-24-000234

As of 2024-06-30

5,404
Source

10-Q · 2026-05-13 · 0001663577-26-000141

As of 2026-03-31

5,404
Source

10-Q · 2025-05-14 · 0001663577-25-000136

As of 2025-03-31

4,540
Source

10-Q · 2024-05-15 · 0001663577-24-000137

As of 2024-03-31

5,404
Source

10-K · 2026-03-31 · 0001663577-26-000087

As of 2025-12-31

5,317
Source

10-K · 2025-04-14 · 0001663577-25-000110

As of 2024-12-31

4,540
Source

10-K · 2024-04-16 · 0001663577-24-000119

As of 2023-12-31

4,540
Source

10-K · 2023-03-30 · 0001663577-23-000137

As of 2022-12-31

Additional Paid in CapitalUSD30,741,991
Source

10-Q · 2025-11-13 · 0001663577-25-000309

As of 2025-09-30

30,387,555
Source

10-Q · 2024-11-19 · 0001663577-24-000294

As of 2024-09-30

30,741,991
Source

10-Q · 2026-08-13 · 0001663577-26-000248

As of 2026-06-30

30,741,991
Source

10-Q · 2025-08-13 · 0001663577-25-000261

As of 2025-06-30

30,387,555
Source

10-Q · 2024-08-15 · 0001663577-24-000234

As of 2024-06-30

30,741,991
Source

10-Q · 2026-05-13 · 0001663577-26-000141

As of 2026-03-31

30,741,991
Source

10-Q · 2025-05-14 · 0001663577-25-000136

As of 2025-03-31

30,352,905
Source

10-Q · 2024-05-15 · 0001663577-24-000137

As of 2024-03-31

30,741,991
Source

10-K · 2026-03-31 · 0001663577-26-000087

As of 2025-12-31

30,684,878
Source

10-K · 2025-04-14 · 0001663577-25-000110

As of 2024-12-31

30,352,905
Source

10-K · 2024-04-16 · 0001663577-24-000119

As of 2023-12-31

30,352,905
Source

10-K · 2023-03-30 · 0001663577-23-000137

As of 2022-12-31

Retained Earnings (Accumulated Deficit)USD-40,751,819
Source

10-Q · 2025-11-13 · 0001663577-25-000309

As of 2025-09-30

-40,260,913
Source

10-Q · 2024-11-19 · 0001663577-24-000294

As of 2024-09-30

-41,532,893
Source

10-Q · 2026-08-13 · 0001663577-26-000248

As of 2026-06-30

-40,501,574
Source

10-Q · 2025-08-13 · 0001663577-25-000261

As of 2025-06-30

-39,974,309
Source

10-Q · 2024-08-15 · 0001663577-24-000234

As of 2024-06-30

-41,277,360
Source

10-Q · 2026-05-13 · 0001663577-26-000141

As of 2026-03-31

-40,227,147
Source

10-Q · 2025-05-14 · 0001663577-25-000136

As of 2025-03-31

-39,670,860
Source

10-Q · 2024-05-15 · 0001663577-24-000137

As of 2024-03-31

-41,010,176
Source

10-K · 2026-03-31 · 0001663577-26-000087

As of 2025-12-31

-39,946,142
Source

10-K · 2025-04-14 · 0001663577-25-000110

As of 2024-12-31

-39,380,488
Source

10-K · 2024-04-16 · 0001663577-24-000119

As of 2023-12-31

-36,998,048
Source

10-K · 2023-03-30 · 0001663577-23-000137

As of 2022-12-31

Stockholders' Equity Attributable to ParentUSD-10,004,424
Source

10-Q · 2025-11-13 · 0001663577-25-000309

As of 2025-09-30

-9,867,468
Source

10-Q · 2025-11-13 · 0001663577-25-000309

As of 2024-09-30

-10,785,498
Source

10-Q · 2026-08-13 · 0001663577-26-000248

As of 2026-06-30

-9,754,179
Source

10-Q · 2026-08-13 · 0001663577-26-000248

As of 2025-06-30

-9,581,864
Source

10-Q · 2025-08-13 · 0001663577-25-000261

As of 2024-06-30

-10,529,965
Source

10-Q · 2026-05-13 · 0001663577-26-000141

As of 2026-03-31

-9,479,752
Source

10-Q · 2026-05-13 · 0001663577-26-000141

As of 2025-03-31

-9,313,415
Source

10-Q · 2025-05-14 · 0001663577-25-000136

As of 2024-03-31

-10,262,781
Source

10-K · 2026-03-31 · 0001663577-26-000087

As of 2025-12-31

-9,245,947
Source

10-K · 2025-04-14 · 0001663577-25-000110

As of 2024-12-31

-9,023,043
Source

10-K · 2024-04-16 · 0001663577-24-000119

As of 2023-12-31

-6,640,603
Source

10-K · 2023-03-30 · 0001663577-23-000137

As of 2022-12-31

Liabilities and EquityUSD133,623
Source

10-Q · 2025-11-13 · 0001663577-25-000309

As of 2025-09-30

148,643
Source

10-Q · 2024-11-19 · 0001663577-24-000294

As of 2024-09-30

123,334
Source

10-Q · 2026-08-13 · 0001663577-26-000248

As of 2026-06-30

143,375
Source

10-Q · 2025-08-13 · 0001663577-25-000261

As of 2025-06-30

163,058
Source

10-Q · 2024-08-15 · 0001663577-24-000234

As of 2024-06-30

119,419
Source

10-Q · 2026-05-13 · 0001663577-26-000141

As of 2026-03-31

149,554
Source

10-Q · 2025-05-14 · 0001663577-25-000136

As of 2025-03-31

153,403
Source

10-Q · 2024-05-15 · 0001663577-24-000137

As of 2024-03-31

127,567
Source

10-K · 2026-03-31 · 0001663577-26-000087

As of 2025-12-31

158,217
Source

10-K · 2025-04-14 · 0001663577-25-000110

As of 2024-12-31

162,869
Source

10-K · 2024-04-16 · 0001663577-24-000119

As of 2023-12-31

246,793
Source

10-K · 2023-03-30 · 0001663577-23-000137

As of 2022-12-31

Current liabilities:
Liabilities, CurrentUSD4,765,644
Source

10-Q · 2025-11-13 · 0001663577-25-000309

As of 2025-09-30

4,643,708
Source

10-Q · 2024-11-19 · 0001663577-24-000294

As of 2024-09-30

5,536,429
Source

10-Q · 2026-08-13 · 0001663577-26-000248

As of 2026-06-30

4,525,151
Source

10-Q · 2025-08-13 · 0001663577-25-000261

As of 2025-06-30

4,023,571
Source

10-Q · 2024-08-15 · 0001663577-24-000234

As of 2024-06-30

5,276,981
Source

10-Q · 2026-05-13 · 0001663577-26-000141

As of 2026-03-31

4,256,903
Source

10-Q · 2025-05-14 · 0001663577-25-000136

As of 2025-03-31

4,094,415
Source

10-Q · 2024-05-15 · 0001663577-24-000137

As of 2024-03-31

5,017,945
Source

10-K · 2026-03-31 · 0001663577-26-000087

As of 2025-12-31

3,679,686
Source

10-K · 2025-04-14 · 0001663577-25-000110

As of 2024-12-31

3,512,407
Source

10-K · 2024-04-16 · 0001663577-24-000119

As of 2023-12-31

3,644,986
Source

10-K · 2023-03-30 · 0001663577-23-000137

As of 2022-12-31

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2026Q2 2025Q1 2026Q1 2025FY 2025FY 2024FY 2023FY 2022
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization———
Source

10-Q · 2025-11-13 · 0001663577-25-000309

2025-07-01 to 2025-09-30

—
Source

10-Q · 2025-11-13 · 0001663577-25-000309

2024-07-01 to 2024-09-30

—
Source

10-Q · 2026-08-13 · 0001663577-26-000248

2026-04-01 to 2026-06-30

—
Source

10-Q · 2026-08-13 · 0001663577-26-000248

2025-04-01 to 2025-06-30

—
Source

10-Q · 2026-05-13 · 0001663577-26-000141

2026-01-01 to 2026-03-31

—
Source

10-Q · 2026-05-13 · 0001663577-26-000141

2025-01-01 to 2025-03-31

—
Source

10-K · 2026-03-31 · 0001663577-26-000087

2025-01-01 to 2025-12-31

—
Source

10-K · 2025-04-14 · 0001663577-25-000110

2024-01-01 to 2024-12-31

—
Source

10-K · 2024-04-16 · 0001663577-24-000119

2023-01-01 to 2023-12-31

—
Source

10-K · 2023-03-30 · 0001663577-23-000137

2022-01-01 to 2022-12-31

Changes in operating assets and liabilities:
Increase (Decrease) in Accounts ReceivableUSD———————4,530
Source

10-Q · 2026-05-13 · 0001663577-26-000141

2025-01-01 to 2025-03-31

———-18,991
Source

10-K · 2023-03-30 · 0001663577-23-000137

2022-01-01 to 2022-12-31

Net Cash Provided by (Used in) Operating ActivitiesUSD——————-822
Source

10-Q · 2026-05-13 · 0001663577-26-000141

2026-01-01 to 2026-03-31

-31,720
Source

10-Q · 2026-05-13 · 0001663577-26-000141

2025-01-01 to 2025-03-31

-38,410
Source

10-K · 2026-03-31 · 0001663577-26-000087

2025-01-01 to 2025-12-31

-69,834
Source

10-K · 2025-04-14 · 0001663577-25-000110

2024-01-01 to 2024-12-31

-77,157
Source

10-K · 2024-04-16 · 0001663577-24-000119

2023-01-01 to 2023-12-31

45,170
Source

10-K · 2023-03-30 · 0001663577-23-000137

2022-01-01 to 2022-12-31

Cash flows from investing activities:
Net Cash Provided by (Used in) Investing ActivitiesUSD————————-4,086
Source

10-K · 2026-03-31 · 0001663577-26-000087

2025-01-01 to 2025-12-31

-9,218
Source

10-K · 2025-04-14 · 0001663577-25-000110

2024-01-01 to 2024-12-31

-9,333
Source

10-K · 2024-04-16 · 0001663577-24-000119

2023-01-01 to 2023-12-31

-2,530
Source

10-K · 2023-03-30 · 0001663577-23-000137

2022-01-01 to 2022-12-31

Cash flows from financing activities:
Net Cash Provided by (Used in) Financing ActivitiesUSD———————34,780
Source

10-Q · 2026-05-13 · 0001663577-26-000141

2025-01-01 to 2025-03-31

34,780
Source

10-K · 2026-03-31 · 0001663577-26-000087

2025-01-01 to 2025-12-31

88,500
Source

10-K · 2025-04-14 · 0001663577-25-000110

2024-01-01 to 2024-12-31

6,000
Source

10-K · 2024-04-16 · 0001663577-24-000119

2023-01-01 to 2023-12-31

-27,299
Source

10-K · 2023-03-30 · 0001663577-23-000137

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD——————-822
Source

10-Q · 2026-05-13 · 0001663577-26-000141

2026-01-01 to 2026-03-31

3,060
Source

10-Q · 2026-05-13 · 0001663577-26-000141

2025-01-01 to 2025-03-31

-7,716
Source

10-K · 2026-03-31 · 0001663577-26-000087

2025-01-01 to 2025-12-31

9,448
Source

10-K · 2025-04-14 · 0001663577-25-000110

2024-01-01 to 2024-12-31

-80,490
Source

10-K · 2024-04-16 · 0001663577-24-000119

2023-01-01 to 2023-12-31

15,341
Source

10-K · 2023-03-30 · 0001663577-23-000137

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD——645
Source

10-Q · 2025-11-13 · 0001663577-25-000309

As of 2025-09-30

612
Source

10-Q · 2025-11-13 · 0001663577-25-000309

As of 2024-09-30

3,959
Source

10-Q · 2026-08-13 · 0001663577-26-000248

As of 2026-06-30

120
Source

10-Q · 2026-08-13 · 0001663577-26-000248

As of 2025-06-30

1,798
Source

10-Q · 2026-05-13 · 0001663577-26-000141

As of 2026-03-31

13,396
Source

10-Q · 2026-05-13 · 0001663577-26-000141

As of 2025-03-31

2,620
Source

10-K · 2026-03-31 · 0001663577-26-000087

As of 2025-12-31

10,336
Source

10-K · 2025-04-14 · 0001663577-25-000110

As of 2024-12-31

888
Source

10-K · 2024-04-16 · 0001663577-24-000119

As of 2023-12-31

81,378
Source

10-K · 2023-03-30 · 0001663577-23-000137

As of 2022-12-31

Additional Financial Items
Amortization of Debt Issuance Costs and DiscountsUSD—————————50,973
Source

10-K · 2025-04-14 · 0001663577-25-000110

2024-01-01 to 2024-12-31

1,278,901
Source

10-K · 2024-04-16 · 0001663577-24-000119

2023-01-01 to 2023-12-31

660,686
Source

10-K · 2023-03-30 · 0001663577-23-000137

2022-01-01 to 2022-12-31

Gain (Loss) on Extinguishment of DebtUSD—————————697,249
Source

10-K · 2025-04-14 · 0001663577-25-000110

2024-01-01 to 2024-12-31

—144,379
Source

10-K · 2023-03-30 · 0001663577-23-000137

2022-01-01 to 2022-12-31

Net Income (Loss) Attributable to ParentUSD——-250,245
Source

10-Q · 2025-11-13 · 0001663577-25-000309

2025-07-01 to 2025-09-30

-286,604
Source

10-Q · 2025-11-13 · 0001663577-25-000309

2024-07-01 to 2024-09-30

-255,533
Source

10-Q · 2026-08-13 · 0001663577-26-000248

2026-04-01 to 2026-06-30

-274,427
Source

10-Q · 2026-08-13 · 0001663577-26-000248

2025-04-01 to 2025-06-30

-267,184
Source

10-Q · 2026-05-13 · 0001663577-26-000141

2026-01-01 to 2026-03-31

-281,005
Source

10-Q · 2026-05-13 · 0001663577-26-000141

2025-01-01 to 2025-03-31

-1,064,034
Source

10-K · 2026-03-31 · 0001663577-26-000087

2025-01-01 to 2025-12-31

-565,654
Source

10-K · 2025-04-14 · 0001663577-25-000110

2024-01-01 to 2024-12-31

-2,382,440
Source

10-K · 2024-04-16 · 0001663577-24-000119

2023-01-01 to 2023-12-31

-1,224,887
Source

10-K · 2023-03-30 · 0001663577-23-000137

2022-01-01 to 2022-12-31

Operating ExpensesUSD——111,057
Source

10-Q · 2025-11-13 · 0001663577-25-000309

2025-07-01 to 2025-09-30

129,969
Source

10-Q · 2025-11-13 · 0001663577-25-000309

2024-07-01 to 2024-09-30

117,817
Source

10-Q · 2026-08-13 · 0001663577-26-000248

2026-04-01 to 2026-06-30

141,237
Source

10-Q · 2026-08-13 · 0001663577-26-000248

2025-04-01 to 2025-06-30

130,938
Source

10-Q · 2026-05-13 · 0001663577-26-000141

2026-01-01 to 2026-03-31

144,852
Source

10-Q · 2026-05-13 · 0001663577-26-000141

2025-01-01 to 2025-03-31

516,315
Source

10-K · 2026-03-31 · 0001663577-26-000087

2025-01-01 to 2025-12-31

609,589
Source

10-K · 2025-04-14 · 0001663577-25-000110

2024-01-01 to 2024-12-31

510,375
Source

10-K · 2024-04-16 · 0001663577-24-000119

2023-01-01 to 2023-12-31

512,920
Source

10-K · 2023-03-30 · 0001663577-23-000137

2022-01-01 to 2022-12-31

Proceeds from Issuance of Common StockUSD———————24,780
Source

10-Q · 2026-05-13 · 0001663577-26-000141

2025-01-01 to 2025-03-31

24,780
Source

10-K · 2026-03-31 · 0001663577-26-000087

2025-01-01 to 2025-12-31

———
Unrealized Gain (Loss) on DerivativesUSD———6,122
Source

10-Q · 2025-11-13 · 0001663577-25-000309

2024-07-01 to 2024-09-30

—————-3,876
Source

10-K · 2025-04-14 · 0001663577-25-000110

2024-01-01 to 2024-12-31

-4,915
Source

10-K · 2024-04-16 · 0001663577-24-000119

2023-01-01 to 2023-12-31

32,035
Source

10-K · 2023-03-30 · 0001663577-23-000137

2022-01-01 to 2022-12-31

Amortization of Intangible Assets————————————

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2026Q2 2025Q1 2026Q1 2025FY 2025FY 2024FY 2023FY 2022
Total RevenueUSD——5,000
Source

10-Q · 2025-11-13 · 0001663577-25-000309

2025-07-01 to 2025-09-30

5,000
Source

10-Q · 2025-11-13 · 0001663577-25-000309

2024-07-01 to 2024-09-30

5,000
Source

10-Q · 2026-08-13 · 0001663577-26-000248

2026-04-01 to 2026-06-30

5,000
Source

10-Q · 2026-08-13 · 0001663577-26-000248

2025-04-01 to 2025-06-30

5,000
Source

10-Q · 2026-05-13 · 0001663577-26-000141

2026-01-01 to 2026-03-31

5,000
Source

10-Q · 2026-05-13 · 0001663577-26-000141

2025-01-01 to 2025-03-31

20,000
Source

10-K · 2026-03-31 · 0001663577-26-000087

2025-01-01 to 2025-12-31

20,000
Source

10-K · 2025-04-14 · 0001663577-25-000110

2024-01-01 to 2024-12-31

20,000
Source

10-K · 2024-04-16 · 0001663577-24-000119

2023-01-01 to 2023-12-31

279,296
Source

10-K · 2023-03-30 · 0001663577-23-000137

2022-01-01 to 2022-12-31

Cost of Goods and Services Sold————————————
Source

10-K · 2023-03-30 · 0001663577-23-000137

2022-01-01 to 2022-12-31

Selling, General and Administrative ExpenseUSD——105,939
Source

10-Q · 2025-11-13 · 0001663577-25-000309

2025-07-01 to 2025-09-30

124,032
Source

10-Q · 2025-11-13 · 0001663577-25-000309

2024-07-01 to 2024-09-30

112,821
Source

10-Q · 2026-08-13 · 0001663577-26-000248

2026-04-01 to 2026-06-30

136,174
Source

10-Q · 2026-08-13 · 0001663577-26-000248

2025-04-01 to 2025-06-30

125,931
Source

10-Q · 2026-05-13 · 0001663577-26-000141

2026-01-01 to 2026-03-31

139,912
Source

10-Q · 2026-05-13 · 0001663577-26-000141

2025-01-01 to 2025-03-31

496,076
Source

10-K · 2026-03-31 · 0001663577-26-000087

2025-01-01 to 2025-12-31

589,151
Source

10-K · 2025-04-14 · 0001663577-25-000110

2024-01-01 to 2024-12-31

491,604
Source

10-K · 2024-04-16 · 0001663577-24-000119

2023-01-01 to 2023-12-31

494,182
Source

10-K · 2023-03-30 · 0001663577-23-000137

2022-01-01 to 2022-12-31

Operating Income (Loss)USD——-106,057
Source

10-Q · 2025-11-13 · 0001663577-25-000309

2025-07-01 to 2025-09-30

-124,969
Source

10-Q · 2025-11-13 · 0001663577-25-000309

2024-07-01 to 2024-09-30

-112,817
Source

10-Q · 2026-08-13 · 0001663577-26-000248

2026-04-01 to 2026-06-30

-136,237
Source

10-Q · 2026-08-13 · 0001663577-26-000248

2025-04-01 to 2025-06-30

-125,938
Source

10-Q · 2026-05-13 · 0001663577-26-000141

2026-01-01 to 2026-03-31

-139,852
Source

10-Q · 2026-05-13 · 0001663577-26-000141

2025-01-01 to 2025-03-31

-496,315
Source

10-K · 2026-03-31 · 0001663577-26-000087

2025-01-01 to 2025-12-31

-589,589
Source

10-K · 2025-04-14 · 0001663577-25-000110

2024-01-01 to 2024-12-31

-490,375
Source

10-K · 2024-04-16 · 0001663577-24-000119

2023-01-01 to 2023-12-31

-238,432
Source

10-K · 2023-03-30 · 0001663577-23-000137

2022-01-01 to 2022-12-31

Net Income (Loss) Attributable to ParentUSD——-250,245
Source

10-Q · 2025-11-13 · 0001663577-25-000309

2025-07-01 to 2025-09-30

-286,604
Source

10-Q · 2025-11-13 · 0001663577-25-000309

2024-07-01 to 2024-09-30

-255,533
Source

10-Q · 2026-08-13 · 0001663577-26-000248

2026-04-01 to 2026-06-30

-274,427
Source

10-Q · 2026-08-13 · 0001663577-26-000248

2025-04-01 to 2025-06-30

-267,184
Source

10-Q · 2026-05-13 · 0001663577-26-000141

2026-01-01 to 2026-03-31

-281,005
Source

10-Q · 2026-05-13 · 0001663577-26-000141

2025-01-01 to 2025-03-31

-1,064,034
Source

10-K · 2026-03-31 · 0001663577-26-000087

2025-01-01 to 2025-12-31

-565,654
Source

10-K · 2025-04-14 · 0001663577-25-000110

2024-01-01 to 2024-12-31

-2,382,440
Source

10-K · 2024-04-16 · 0001663577-24-000119

2023-01-01 to 2023-12-31

-1,224,887
Source

10-K · 2023-03-30 · 0001663577-23-000137

2022-01-01 to 2022-12-31

Earnings Per Share, DilutedUSD per share———-0.06
Source

10-Q · 2024-11-19 · 0001663577-24-000294

2024-07-01 to 2024-09-30

—————-0.11
Source

10-K · 2025-04-14 · 0001663577-25-000110

2024-01-01 to 2024-12-31

-0.52
Source

10-K · 2024-04-16 · 0001663577-24-000119

2023-01-01 to 2023-12-31

-0.27
Source

10-K · 2023-03-30 · 0001663577-23-000137

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Basicshares——5,403,843
Source

10-Q · 2025-11-13 · 0001663577-25-000309

2025-07-01 to 2025-09-30

4,539,843
Source

10-Q · 2025-11-13 · 0001663577-25-000309

2024-07-01 to 2024-09-30

5,403,843
Source

10-Q · 2026-08-13 · 0001663577-26-000248

2026-04-01 to 2026-06-30

5,403,843
Source

10-Q · 2026-08-13 · 0001663577-26-000248

2025-04-01 to 2025-06-30

5,403,843
Source

10-Q · 2026-05-13 · 0001663577-26-000141

2026-01-01 to 2026-03-31

5,362,787
Source

10-Q · 2026-05-13 · 0001663577-26-000141

2025-01-01 to 2025-03-31

5,393,805
Source

10-K · 2026-03-31 · 0001663577-26-000087

2025-01-01 to 2025-12-31

5,061,350
Source

10-K · 2025-04-14 · 0001663577-25-000110

2024-01-01 to 2024-12-31

4,539,843
Source

10-K · 2024-04-16 · 0001663577-24-000119

2023-01-01 to 2023-12-31

4,539,843
Source

10-K · 2023-03-30 · 0001663577-23-000137

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Dilutedshares———4,539,843
Source

10-Q · 2024-11-19 · 0001663577-24-000294

2024-07-01 to 2024-09-30

—————5,061,350
Source

10-K · 2025-04-14 · 0001663577-25-000110

2024-01-01 to 2024-12-31

4,539,843
Source

10-K · 2024-04-16 · 0001663577-24-000119

2023-01-01 to 2023-12-31

4,539,843
Source

10-K · 2023-03-30 · 0001663577-23-000137

2022-01-01 to 2022-12-31

Additional Financial Items
Depreciation, Depletion and Amortization, NonproductionUSD——5,118
Source

10-Q · 2025-11-13 · 0001663577-25-000309

2025-07-01 to 2025-09-30

5,937
Source

10-Q · 2025-11-13 · 0001663577-25-000309

2024-07-01 to 2024-09-30

4,996
Source

10-Q · 2026-08-13 · 0001663577-26-000248

2026-04-01 to 2026-06-30

5,063
Source

10-Q · 2026-08-13 · 0001663577-26-000248

2025-04-01 to 2025-06-30

5,007
Source

10-Q · 2026-05-13 · 0001663577-26-000141

2026-01-01 to 2026-03-31

4,940
Source

10-Q · 2026-05-13 · 0001663577-26-000141

2025-01-01 to 2025-03-31

20,239
Source

10-K · 2026-03-31 · 0001663577-26-000087

2025-01-01 to 2025-12-31

20,438
Source

10-K · 2025-04-14 · 0001663577-25-000110

2024-01-01 to 2024-12-31

18,771
Source

10-K · 2024-04-16 · 0001663577-24-000119

2023-01-01 to 2023-12-31

18,738
Source

10-K · 2023-03-30 · 0001663577-23-000137

2022-01-01 to 2022-12-31

Gross ProfitUSD——5,000
Source

10-Q · 2025-11-13 · 0001663577-25-000309

2025-07-01 to 2025-09-30

5,000
Source

10-Q · 2025-11-13 · 0001663577-25-000309

2024-07-01 to 2024-09-30

5,000
Source

10-Q · 2026-08-13 · 0001663577-26-000248

2026-04-01 to 2026-06-30

5,000
Source

10-Q · 2026-08-13 · 0001663577-26-000248

2025-04-01 to 2025-06-30

5,000
Source

10-Q · 2026-05-13 · 0001663577-26-000141

2026-01-01 to 2026-03-31

5,000
Source

10-Q · 2026-05-13 · 0001663577-26-000141

2025-01-01 to 2025-03-31

20,000
Source

10-K · 2026-03-31 · 0001663577-26-000087

2025-01-01 to 2025-12-31

20,000
Source

10-K · 2025-04-14 · 0001663577-25-000110

2024-01-01 to 2024-12-31

20,000
Source

10-K · 2024-04-16 · 0001663577-24-000119

2023-01-01 to 2023-12-31

274,488
Source

10-K · 2023-03-30 · 0001663577-23-000137

2022-01-01 to 2022-12-31

Income (Loss) from Continuing Operations, Per Basic ShareUSD per share——-0.05
Source

10-Q · 2025-11-13 · 0001663577-25-000309

2025-07-01 to 2025-09-30

-0.06
Source

10-Q · 2025-11-13 · 0001663577-25-000309

2024-07-01 to 2024-09-30

-0.05
Source

10-Q · 2026-08-13 · 0001663577-26-000248

2026-04-01 to 2026-06-30

-0.05
Source

10-Q · 2026-08-13 · 0001663577-26-000248

2025-04-01 to 2025-06-30

-0.05
Source

10-Q · 2026-05-13 · 0001663577-26-000141

2026-01-01 to 2026-03-31

-0.05
Source

10-Q · 2026-05-13 · 0001663577-26-000141

2025-01-01 to 2025-03-31

-0.2
Source

10-K · 2026-03-31 · 0001663577-26-000087

2025-01-01 to 2025-12-31

-0.11
Source

10-K · 2025-04-14 · 0001663577-25-000110

2024-01-01 to 2024-12-31

-0.52
Source

10-K · 2024-04-16 · 0001663577-24-000119

2023-01-01 to 2023-12-31

-0.27
Source

10-K · 2023-03-30 · 0001663577-23-000137

2022-01-01 to 2022-12-31

Interest ExpenseUSD——144,188
Source

10-Q · 2025-11-13 · 0001663577-25-000309

2025-07-01 to 2025-09-30

167,757
Source

10-Q · 2025-11-13 · 0001663577-25-000309

2024-07-01 to 2024-09-30

142,716
Source

10-Q · 2026-08-13 · 0001663577-26-000248

2026-04-01 to 2026-06-30

142,720
Source

10-Q · 2026-08-13 · 0001663577-26-000248

2025-04-01 to 2025-06-30

141,246
Source

10-Q · 2026-05-13 · 0001663577-26-000141

2026-01-01 to 2026-03-31

141,153
Source

10-Q · 2026-05-13 · 0001663577-26-000141

2025-01-01 to 2025-03-31

572,249
Source

10-K · 2026-03-31 · 0001663577-26-000087

2025-01-01 to 2025-12-31

669,438
Source

10-K · 2025-04-14 · 0001663577-25-000110

2024-01-01 to 2024-12-31

1,887,150
Source

10-K · 2024-04-16 · 0001663577-24-000119

2023-01-01 to 2023-12-31

1,162,869
Source

10-K · 2023-03-30 · 0001663577-23-000137

2022-01-01 to 2022-12-31

Operating ExpensesUSD——111,057
Source

10-Q · 2025-11-13 · 0001663577-25-000309

2025-07-01 to 2025-09-30

129,969
Source

10-Q · 2025-11-13 · 0001663577-25-000309

2024-07-01 to 2024-09-30

117,817
Source

10-Q · 2026-08-13 · 0001663577-26-000248

2026-04-01 to 2026-06-30

141,237
Source

10-Q · 2026-08-13 · 0001663577-26-000248

2025-04-01 to 2025-06-30

130,938
Source

10-Q · 2026-05-13 · 0001663577-26-000141

2026-01-01 to 2026-03-31

144,852
Source

10-Q · 2026-05-13 · 0001663577-26-000141

2025-01-01 to 2025-03-31

516,315
Source

10-K · 2026-03-31 · 0001663577-26-000087

2025-01-01 to 2025-12-31

609,589
Source

10-K · 2025-04-14 · 0001663577-25-000110

2024-01-01 to 2024-12-31

510,375
Source

10-K · 2024-04-16 · 0001663577-24-000119

2023-01-01 to 2023-12-31

512,920
Source

10-K · 2023-03-30 · 0001663577-23-000137

2022-01-01 to 2022-12-31

Other ExpensesUSD——144,188
Source

10-Q · 2025-11-13 · 0001663577-25-000309

2025-07-01 to 2025-09-30

161,635
Source

10-Q · 2025-11-13 · 0001663577-25-000309

2024-07-01 to 2024-09-30

142,716
Source

10-Q · 2026-08-13 · 0001663577-26-000248

2026-04-01 to 2026-06-30

138,190
Source

10-Q · 2026-08-13 · 0001663577-26-000248

2025-04-01 to 2025-06-30

141,246
Source

10-Q · 2026-05-13 · 0001663577-26-000141

2026-01-01 to 2026-03-31

141,153
Source

10-Q · 2026-05-13 · 0001663577-26-000141

2025-01-01 to 2025-03-31

567,719
Source

10-K · 2026-03-31 · 0001663577-26-000087

2025-01-01 to 2025-12-31

-23,935
Source

10-K · 2025-04-14 · 0001663577-25-000110

2024-01-01 to 2024-12-31

1,892,065
Source

10-K · 2024-04-16 · 0001663577-24-000119

2023-01-01 to 2023-12-31

986,455
Source

10-K · 2023-03-30 · 0001663577-23-000137

2022-01-01 to 2022-12-31

Other IncomeUSD—————4,530
Source

10-Q · 2026-08-13 · 0001663577-26-000248

2025-04-01 to 2025-06-30

——4,530
Source

10-K · 2026-03-31 · 0001663577-26-000087

2025-01-01 to 2025-12-31

———
Amortization of Intangible Assets————————————

Lines labelled “Derived” are calculated from reported figures.

Filing attachments

ex99_1.htm · 8-K · 2025-01-23

EX-99.1 5 ex99_1.htm PRESS RELEASE, DATED JANUARY 23, 2025 Skinvisible Reports Licensee Success in Netherton Syndrome Clinical Studies Topic: Company Update Thursday, 23 January 2025 05:30 AM LAS VEGAS, NV / ACCESS Newswire / January 23, 2025 / Skinvisible Pharmaceuticals, Inc. ("Skinvisible" or "the Company"), (OTCQB: SKVI ), an innovative topical and transdermal pharmaceutical research and development company, with proprietary Invisicare® drug delivery technology, today announces signi…

8-K · 2025-01-23 · 0001663577-25-000033

Read attachment ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.